Co-existing problems of mental health and substance misuse (dual diagnosis): A literature review

Drugs: Education, Prevention and Policy

Volumn 10, Issue SUPPL., 2003, Pages

  Crawford, Vanessa ^a   Crome, Ilana B ^b   Clancy, Carmel ^c  

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038053004     PISSN: 09687637     EISSN: None     Source Type: Journal    
DOI: 10.1080/0968763031000072990     Document Type: Review

References (138)

1. ADDINGTON, J. & ADDINGTON, D. (1997). Substance abuse and cognitive functioning in schizophrenia. Journal of Psychiatric Neuroscience, 22, 99-104. (Canada)
2. ADDINGTON, J. & ADDINGTON, D. (1998). Effect of substance misuse in early psychosis. British Journal of Psychiatry, 172, 13-46. (Canada)
3. ADDINGTON, J. & DUCHAK, V. (1997). Reasons for substance use in schizophrenia. Acta Psychiatrica Scandinavica, 96, 32933. (CANADA)
4. ALAJA, R., SEPPA, K., SILLANAUKEE, P. et al. (1997). Psychiatric referrals associated with substance use disorders: prevalence and gender differences. Alcoholism: Clinical and Experimental Research, 21, 620-6. (FINLAND)
5. ALEXANDER, M.J. (1996). Women with co-occurring addictive and mental disorders: an emerging profile of vulnerability. American Journal of Orthopsychiatry, 66, 61-70. (USA)
6. APPLEBY, L. (2000). Drug misuse and suicide: a tale of two services. Addiction, 95, 17-5-7. (USA)
7. APPLEBY, L., DYSON, V., ALTMAN, E. et al. (1996). Utility of the chemical use, abuse, and dependence scale in screening patients with severe mental illness. Psychiatric Services, 47, 647-9. (USA)
8. APPLEBY, L., DYSON, V., ALTMAN, E. et al. (1997). Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population. The Journal of Nervous and Mental Disease, 185, 159-165.
9. ARNDT, S., TYRRELL, G., FLAUM, M. et al. (1992). Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine, 22, 379-88. (USA)
10. BAIGENT, B., HOLME, G. & HAFNER, R.J. (1995). Self reports of the interaction between substance abuse and schizophrenia. Australia and New Zealand Journal of Psychiatry, 29, 69-74. (AUSTRALIA)
11. BALL, S.A. (1998). Manualised treatment for substance abusers with personality disorders: dual focus schema therapy. Addictive Behaviours, 23, 883-91. (USA)
12. BARNARD, J. (2000). Crossing the gap identifying clients of dual diagnosis. DrugLink, March/April 2000. (UK)
13. BEBOUT, R.R., DRAKE, R.E., XIE, H. et al. (1997). Housing status among formerly homeless dually diagnosed adults. Psychiatric Services, 48, 936-41. (USA)
14. BERNSTEIN, D.P., STEIN, J.A. & HANDELSMAN, L. (1998). Predicting personality pathology among adult patients with substance use disorders: effects of childhood maltreatment. Addictive Behaviors, 23, 855-68. (USA)
15. BLUME, A.W. & MARLATT, G.A. (2000). Recent important substance-related losses predict readiness to change scores among people with co-occurring psychiatric disorders. Addictive Behaviours, 25, 461-4. (USA)
16. BLUME, A.W., DAVIS, M.J. & SCHMALING, K.B. (1999). Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change. Journal of Psychoactive Drugs, 31, 111-15. (USA)
17. BRADY, K., CASTO, S., LYDIARD, R.B. et al. (1991). Substance abuse in an in-patient psychiatric sample. American Journal of Drug and Alcohol Abuse, 17(4), 389-97. (USA)
18. BRADY, K.T. & SONNE, S.C. (1995). The relationship between substance abuse and bipolar disorder. Journal of Clinical Psychiatry, 56, 19-24. (USA)
19. BRADY, K.T., DANSKY, B.S., SONNE, S.C. et al. (1998). Posttraumatic stress disorder and cocaine dependence. The American Journal on Addictions, 7, 128-35. (USA)
20. BRIZER, D.A., HARTMAN, N., SWEENEY, J. et al. (1985). Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia. American Journal of Psychiatry, 142, 1106-7. (USA)
21. BROONER, R.K., KING, V.L., KIDORF, M., et al. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71-80. (USA)
22. BROWN, V.B., MELCHIOR, L.A. & HUBA, G.J. (1999). Level of burden among women diagnosed with severe mental illness and substance abuse. Journal of Psychoactive Drugs, 31, 31-40. (USA)
23. BUCKLEY, P.F. (1998). Substance abuse in schizophrenia: a review. Journal of Clinical Psychiatry, 59, 26-30. (USA)
24. BUSTO, E.S., ROMACH, M.K. & SELLERS, E.M. (1996). Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. Journal of Clinical Psychopharmacology, 16, 51-7. (CANADA)
25. CAREY, K.B. & CORREIA, C.J. (1998). Severe mental illness and addictions: assessment considerations. Addictive Behaviors, 23, 735-48. (USA)
26. CAREY, KB., MAISTO, S.A., CAREY, M.P. et al. (2001) Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measures. Journal of Studies on Alcohol, 62, 79-88.
27. CARROLL, K.M., NICH, C. & ROUNSAVILLE, B.J. (1995). Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. The Journal of Nervous and Mental Disease, 183, 251-9. (USA)
28. CECERO, J.J., BALL, S.A., TENNEN, H. et al. (1999). Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers. Journal of Nervous and Mental Diseases, 187, 478-86. (USA)
29. CHILCOAT, H.D. & BRESLAU, B. (1998). Investigation of causal pathways between PTSD and drug use disorders. Addictive Behaviors, 23, 827-40. (USA)
30. CLARK, R.E., TEAGUE, G.B., RICKETTS, S.K. et al. (1998). Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders. Health Services Research, 33, 1285-308. (USA)
31. CORNELIUS, J.R., SALLOUM, I.M., EHLER, J.G. et al. (1997). Fluoxetine in depressed alcoholics: a double blind, placebo-controlled trial. Archives of General Psychiatry, 54, 700-5. (USA)
32. CORNELIUS, J.R., SALLOUM, I.M., HASKETT, R.F. et al. (1999). Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addictive Behaviors, 24, 111-14. (USA)
33. COTTLER, L.B., COMPTON, W.M., RIDENOUR, T.A. et al. (1998). Reliability of self-reported antisocial personality disorder symptoms among substance abusers. Drug and Alcohol Dependence, 49, 189-99. (USA)
34. CRAWFORD, V. (1996). Comorbidity of substance misuse and psychiatric disorders. Current Opinion in Psychiatry, 9, 231-4. (UK)
35. CROME, I.B. (1997). Gender differences in substance misuse and psychiatric comorbidity. Current Opinion in Psychiatry, 10, 194-8. (UK)
36. CROME, I.B. (1999a). The trouble with training: substance misuse education in British medical schools revisited. What are the issues? Drugs: Education, Prevention and Policy, 6, 111-23. (UK)
37. CROME, I.B. (1999b). Substance misuse and psychiatric comorbidity: towards improved service provision. Drugs: Education, Prevention and Policy, 6, 151-74. (UK)
38. CUFFEL, B.J. & CHASE, P. (1994). Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. The Journal of Nervous and Mental Disease, 182, 342-8. (USA)
39. DALEY, D.C., SALLOUM, I.M., ZUCKOFF, A. et al. (1998). Increasing treatment adherence among outpatients with depression and cocaine dependence: results of a pilot study. American Journal of Psychiatry, 155, 1611-13. (USA)
40. DARKE, S. & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence, 48, 135-41. (AUSTRALIA)
41. D'ERCOLE, A., STRUENING, E., CURTIS, J.L. et al. (1997). Effects of diagnosis, demographic characteristics, and case management on rehospitalisation. Psychiatric Services, 48, 682-8. (USA)
42. DE LEON, G, SACKS, S., STAINES, G. et al. (1999). Modified therapeutic community for homeless mentally ill chemical abusers: emerging subtypes. American Journal of Drug and Alcohol Abuse, 25, 495-515. (USA).
43. DIXON, L., HAAS, G., WEIDEN, P., et al. (1990). Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophrenia Bulletin, 16, 69-78. (USA)
44. DIXON, L., WEIDEN, P., TORRES, M. et al. (1997). Assertive community treatment and medication compliance in the homeless mentally ill. American Journal of Psychiatry, 154, 1302-4. (USA)
45. DIXON, L., POSTRADO, L., DELAHANTY, J. et al. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. The Journal of Nervous and Mental Disease, 187, 496-502. (USA)
46. DOWNEY, K.K., STELSON, F.W., POMERLEAU, O.F. et al. (1997). Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. The Journal of Nervous and Mental Disease, 185, 32-8. (USA)
47. DRAKE, R.E. & MUESER, K.T. (2000). Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin, 26, 105-18. (USA)
48. DRAKE, R.E., YOVETICH, N.A., BEBOUT, R.R. et al. (1997). Integrated treatment for dually diagnosed homeless adults. The Journal of Nervous and Mental Disease, 185, 298-305. (USA)
49. DRAKE, R.E., MERCER-McFADDEN, C., MUESER, K.T. et al. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589-608. (USA)
50. FARRELL, M., HOWES, S., TAYLOR, C. et al. (1998). Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric comorbidity survey. Addictive Behaviors, 23, 909-18. (UK)
51. FARREN, C.K. & O'MALLEY, S.S. (1999). Occurrence and management of depression in the context of naltrexone treatment of alcoholism. American Journal of Psychiatry, 156, 1258-62. (USA)
52. FEINMAN, J.A. & DUNNER, D.L. (1996). The effect of alcohol and substance abuse on the course of bipolar affective disorder. Journal of Affective Disorders, 37, 43-9. (USA)
53. FISHER, M.S. & BENTLEY, K.J. (1996). Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder. Psychiatric Services, 47, 124-49. (USA)
54. FOWLER, I.L., CARR, V.J., CARTER, N.T. et al. (1998). Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin, 24, 44355. (AUSTRALIA)
55. GALANTER, M., EGELKO, S., EDWARDS, H. et al. (1994). A treatment system for combined psychiatric and addictive illness. Addiction, 89, 1227-35. (USA)
56. GALANTER, M., EGELKO, S., EDWARDS, H. et al. (1996). Can cocaine addicts with severe mental illness be treated along with singly diagnosed addicts? American Journal of Drug and Alcohol Abuse, 22, 497-507. (USA)
57. GEARON, J.S. & BELLACK, A.S. (1999). Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimisation and HIV. Community Mental Health Journal, 35, 401-19. (USA)
58. GEARON, J.S. & BELLACK, A.S. (2000). Sex differences in illness presentation, course, and level of functioning in substance-abusing schizophrenia patients. Schizophrenia Research, 43, 65-70. (USA)
59. GLASS, I.B. (1989). Undergraduate training in substance abuse in the United Kingdom. British Journal of Addiction, 84, 197-202.
60. GLAZER, W.M. (1997). Olanzapine and the new generation of antipsychotic agents: patterns of use. Journal of Clinical Psychiatry, 58, 18-21. (USA)
61. GOLDBERG, J.F., GARNO, J.L., LEON, A.C. et al. (1999). A history of substance abuse complicates remission from acute mania in bipolar disorder. Journal of Clinical Psychiatry, 60, 733-40. (USA)
62. GOLDSMITH, R.J. (1999). Overview of psychiatric comorbidity. Practical and theoretical considerations. Addictive Disorders, 22, 331-49. (USA)
63. GOURNAY, K., SANDFORD, T., JOHNSON, G. et al. (1997). Dual diagnosis of severe mental health problems and substance abuse/dependence: a major priority for mental health nursing. Journal of Psychiatric and Mental Health Nursing, 4, 89-95. (UK)
64. GOVSPARI, D. (1999). Cannabis and schizophrenia: results of a follow-up study. Psychiatry and Clinical Neuroscience, 249, 45-9. (GERMANY)
65. GRANT, B.F. & HASIN, D.S. (1999). Suicidal ideation among the United States drinking population: results from the national longitudinal alcohol epidemiologic survey. Journal of Studies on Alcohol, 60, 422-9. (USA)
66. GREENBERG, W.M. (1994). Irregular discharges from a dual diagnosis unit. American Journal of Drug and Alcohol Abuse, 20, 355-71. (USA)
67. HAMILTON, S.P., KLIMCHAK, C. & NUNES, E.V. (1998). Treatment of depressed methadone maintenance patients with nefazodone. The American Journal on Addictions, 7, 309-12. (USA)
68. HANNA, E.Z. & GRANT, B.F. (1999). Parallels to early onset alcohol use in the relationship of early onset smoking with drug use and DSM-1V drug and depressive disorders: findings from the national longitudinal epidemiological survey. Alcoholism: Clinical and Experimental Research, 23, 513-22. (USA)
69. HASIN, D.S., TRAUTMAN, K.D., MIELE, G.M. et al. (1996). Psychiatric research interview for substance and mental disorders (PRISM): reliability for substance abusers. American Journal of Psychiatry, 153, 1195-201 (USA)
70. HEIL, S.H., BADGER, G., HIGGINS, S.T. et al. (2001). Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics. Journal of Studies on Alcohol, 62, 14-22. (USA)
71. HIEN, H.A., NUNES, E., LEVIN, F.R. et al. (2000). Posttraumatic stress disorder and short-term outcome in early methadone treatment. Journal of Substance Abuse Treatment, 19, 31-7. (USA)
72. HIPWELL, A.B., SINGH, K. & CLARK, A. (2000). Substance misuse among clients with severe and enduring mental illness: service utilisation and implications for clinical management. Journal of Mental Health, 9, 37-50. (UK)
73. Ho, A.P., TSUANG, J.W., LIBERMAN, R.P. et al. (1999). Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence. American Journal of Psychiatry, 156, 1765-70. (USA)
74. HOFF, R.A. & ROSENHECK, R.A. (1998). Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders. Medical Care, 36, 835-43. (USA)
75. HOFF, R.A. & ROSENHECK, R.A. (1999). The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatric Services, 50, 1309-15. (USA)
76. JARVIS, T.J. & COPELAND, J. (1997). Child sexual abuse as a predictor of psychiatric comorbidity and its implications for drug and alcohol treatment. Drug and Alcohol Dependence, 49, 61-9. (AUSTRALIA)
77. JOHNS, A. (2001). Psychiatric effects of cannabis. British Journal of Psychiatry, 178, 116-22. (UK)
78. KENDLER, K.S., DAVE, C.G. & KESSLER, R.C. (1997). The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history. British Journal of Psychiatry, 170, 541-8. (USA)
79. KOFOED, L., FRIEDMAN, M.J. & PECK, R. (1993). Alcoholism and drug abuse in patients with PTSD. Psychiatric Quarterly, 2, 151-71. (USA)
80. KOKKEVI, A. & STEPANIS, C. (1995). Drug abuse and psychiatric comorbidity. Comprehensive Psychiatry, 36, 329-37. (GREECE)
81. KRANZLER, H.R., KADDEN, R.M., BURLESON, J.A. et al. (1995). Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? Comprehensive Psychiatry, 36, 278-88. (USA)
82. KUMPULAINEN, K. (2000). Psychiatric symptoms and deviance in early adolescence predict heavy alcohol use three years later. Addiction, 95, 1847-57. (FINLAND)
83. LAAKSO, M.P., VAURIO, O., SAVOLAINEN, L. et al. (2000). A volumetric MRI study of the hippocampus in type 1 and type 2 alcoholism. Behavioural Brain Research, 109, 177-86. (FINLAND)
84. LAUDET, A.B., MAGURA, S., VOGEL, H.S. et al. (2000). Recovery challenges among dually diagnosed individuals. Journal of Substance Abuse Treatment, 18, 321-9. (USA)
85. LEVIN, F.R., EVANS, S.M., COOMARASWAMMY, S. et al. (1998). Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. American Journal of Drug and Alcohol Abuse, 24, 343-60. (USA)
86. LINEMAN, M.M., SCHMIDT, H., DIMEFF, L.A., et al. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug dependence. The American Journal on Addictions, 8, 279-92. (USA)
87. LIRAUD, F. & VERDOUX, H. (2000). Which temperamental characteristics are associated with substance use in subjects with psychotic and mood disorders? Psychiatry Research, 93, 63-72. (FRANCE)
88. LUKE, D.A., MOWBRAY, C.T., KLUMP, K. et al. (1996). Exploring the diversity of dual diagnosis: utility of cluster analysis for program planning. The Journal of Mental Health Administration, 23, 298-316. (USA)
89. MAISTO, S.A., CAREY, M.P., CAREY, K.B. et al. (2000). Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychological Assessment, 12, 186-92. (USA)
90. MARLOWE, D.B., KIRBY, K.C. & FESTINGER, D.S. (1997). Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioural treatment for cocaine dependence. The Journal of Nervous and Mental Disease, 185, 483-90. (USA)
91. MARSDEN, J., GOSSOP, M., STEWART, D. et al. (2000). Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. British Journal of Psychiatry, 176, 285-9. (UK)
92. McCRONE, P., MENEZES, P.R., JOHNSON, S. et al. (2000). Service use and costs of people with dual diagnosis in south London. Acta Psychiatrica Scandinavica, 101, 464-72. (UK)
93. McHUGO, G.J., DRAKE, R.E., BURTON, H.L. et al. (1995). A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. The Journal of Nervous and Mental Disease, 183, 762-7. (USA)
94. McHUGO, G.J., DRAKE, R.E., TEAGUE, G.B. et al. (1999). Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services, 50, 818-24. (USA)
95. McPHILLIPS, M.A., KELLY, F.J., BARNES, T.E. et al. (1997). Detecting co-morbid substance abuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine. Schizophrenia Research, 25, 141-8. (UK)
96. MEEK, P.S., CLARK, H.W. & SOLANA, V.L. (1989). Neurocognitive impairment: the unrecognised component of dual diagnosis in substance abuse treatment. Journal of Psychoactive Drugs, 21, 153-60 (USA)
97. MILLER, N.S. (1993). Comorbidity of psychiatric and alcohol/drug disorders: interactions and independent status. Comorbidity of Addictive and Psychiatric Disorders. Haworth Press, Binghampton, NY, pp. 5-16. (USA)
98. MOGGI, F., OULMETTE, P.C. & MOOS, R.H. (1999). Dual diagnosis patients in substance abuse treatment: relationship of general coping and substance-specific coping to one-year outcomes. Addiction, 94, 1805-16. (USA)
99. NUNES, E.V., QUITKIN, P.M., DONOVAN, S.J. et al. (1998). Imipramine treatment of opiate-dependent patients with depressive disorders. Archives of General Psychiatry, 55, 153-9. (USA)
100. O'BOYLE, M. & BRANDON, E.A.A. (1998). Suicide attempts, substance abuse, and personality. Journal of Substance Abuse Treatment, 4, 353-6. (USA)
101. OUIMETTE, P.C., FINNEY, J.W., GIMA, K. et al. (1999). A comparative evaluation of substance abuse treatment 111. Examining mechanisms underlying patienttreatment matching hypotheses for 12-step and cognitive-behavioural treatments for substance abuse. Alcoholism: Clinical and Experimental Research, 23, 545-51. (USA)
102. OYEFESO, A., GHODSE, H., CLANCY, C. & CORKERY, J.M. (1999). Suicide among drug addicts in the UK. British Journal of Psychiatry, 175, 277-82. (UK)
103. PAGES, K.P., RUSSON, J.E., ROY-BYRNE, P.P. et al. (1997). Determinants of suicidal ideation: the role of substance use disorders. Journal of Clinical Psychiatry, 58, 510-15. (USA)
104. PENK, W.E., FLANNERY, R.B., IRVIN, E. et al. (2000). Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed. Journal of Addictive Diseases, 19, 23-30. (USA)
105. POST AHRENS, M. (1998). A model for dual disorder treatment in acute psychiatry in a VA population. Journal of Substance Abuse Treatment, 15, 107-12. (USA)
106. REGIER, D.A., RAE, D.S., NARROW, W.E. et al. (1998). Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of Psychiatry, 173, 24-8. (USA)
107. RIES, R.K., RUSSO, J., WINGERSON, D. et al. (2000). Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance use disorders. Psychiatric Services, 51, 210-15. (USA)
108. ROBINS, L.N. (1998). The intimate connection between antisocial personality and substance abuse. Social Psychiatry and Psychiatric Epidemiology, 33, 393-9. (USA)
109. ROSENBERG, S.D., DRAKE, R.E., WOLFORD, G.L. et al. (1998). Dartmouth assessment of lifestyle instrument (DALI): a substance use disorder screen for people with severe mental illness. The American Journal of Psychiatry, 155, 232-8. (USA)
110. ROSEN-CHASE, C. & DYSON, V. (1998). Treatment of nicotine dependence in the chronic mentally ill. Journal of Substance Abuse Treatment, 16, 315-20. (USA)
111. ROUNSAVILLE, B.J., KRANZLER, H.R., BALL, S. et al. (1998). Personality disorders in substance abusers: relation to substance use. The Journal of Nervous and Mental Disease, 186, 87-95. (USA)
112. RUTHERFORD, M.J., ALTERMAN, A.I., CACCIOLA, J.S. et al. (1995). Gender differences in diagnosing antisocial personality disorder in methadone patients. American Journal of Psychiatry, 152, 1309-16. (USA)
113. SCHELLER-GILKEY, G., LEWINE, R.R.J. & CAUDLE, J. (1999). Schizophrenia, substance use, and brain morphology. Schizophrenia Research, 35, 113-20. (USA)
114. SCHUCKIT, M.A., TIPP, J.E., BUCHOLZ, K.K. et al. (1997). The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction, 92, 1289-304. (USA)
115. SCIACCA, K. (1991). An integrated treatment approach for severely mentally ill individuals with substance use disorders. New Directions in Mental Health Services, Jossey-Bass, Chapter 6, No. 50. (USA)
116. SCOTT, H., JOHNSON, S., MENEZES, P. et al. (1998). Substance misuse and risk of aggression and offending among the severely mentally ill. British Journal of Psychiatry, 172, 345-50. (UK)
117. SERPER, M.R., ALPERT, M., RICHARDSON, N.A. et al. (1995). Clinical effects of recent cocaine use on patients with acute schizophrenia. American Journal of Psychiatry, 152, 1464-9. (USA)
118. SERPER, M.R., BERGMAN, A., COPERSINO, ML. et al. (2000). Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Research, 93, 21-32. (USA)
119. SHANER, A., ROBERTS, L.J., ECKMAN, T.A. et al. (1998). Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatric Services, 49, 684-90. (USA)
120. SLOAN, K.L. (1998). Substance abuse and psychiatric illness: treatment experience. American Journal of Drug and Alcohol Abuse, 24, 589-601. (USA)
121. SOYKA, M., ALBUS, M., KATHMANN, N. et al. (1993). Prevalence of alcohol and drug abuse in schizophrenic in-patients. European Archives of Psychiatry and Clinical Neuroscience, 242, 362-72. (Germany)
122. STRAKOWSKI, S.M., SAX, K.W., McELROY, S.L. et al. (1998). Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalisation. Journal of Clinical Psychiatry, 59, 465-71. (USA)
123. SWANSON, J., BORUM, R., SWARTZ, M. et al. (1999a). Violent behaviour preceding hospitalisation among persons with severe mental illness. Law and Human Behavior, 23, 185-203. (USA)
124. SWANSON, A.J., PANTALON, M.V. & COHEN, K.R. (1999b). Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. The Journal of Nervous and Mental Disease, 187, 630-5. (USA)
125. SWARTZ, M.S., SWANSON, J.W., HIDAY, V.A. et al. (1998). Violence and severe mental illness: the effects of substance abuse and non-adherence to medication. American Journal of Psychiatry, 155, 226-31. (USA)
126. SWOFFORD, C.D., SCHELLER-GILKEY, G., MILLER, A.H. et al. (2000). Double jeopardy: schizophrenia and substance use. American Journal of Drug and Alcohol Abuse, 26, 343-53. (USA)
127. TIDEY, J.W., MEHL-MADRONA, L. & HIGGINS, S.T. (1998). Psychiatric symptom severity in cocaine-dependent outpatients: demographics, drug use characteristics and treatment outcome. Drug and Alcohol Dependence, 50, 9-17. (USA)
128. TRIFFLEMAN, E., CARROLL, K. & KELLOGG, S (1998). Substance dependent posttraumatic stress disorder therapy an integrated cognitive-behavioural approach. Journal of Substance Abuse Treatment, 17, 3-14. (USA)
129. TRULL, T.J., SHER, K.J. & MINKS-BROWN, C. (2000). Borderline personality disorder and substance use disorders: a review and integration. Clinical Psychology Review, 20, 235-53. (USA)
130. TSUANG, D., COWLEY, D., RIES, R. et al. (1995). The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic. Journal of Clinical Psychiatry, 56, 549-54. (USA)
131. VERHEUL, R., KRANZLER, H.R., POLING, J et al. (2000). Axis I and axis II disorders in alcoholics and drug addicts: fact or artifact? Journal of Studies on Alcohol, 61, 101-10. (USA)
132. VERHEUL, R., KRANZLER, H.R., POLING, J. et al. (2000). Co-occurrence of axis I and axis II disorders in substance abusers. Acta Psychiatrica Scandinavica, 101, 110-18. (USA)
133. WESTERMEYER, J.J., SCHNEEKLOTH, T.D. (1999). Course of substance abuse in patients with and without schizophrenia. The American Journal on Addictions, 8, 55-64. (USA)
134. WHEATLEY, M. (1998). The prevalence and relevance of substance use in detained schizophrenic patients. The Journal of Forensic Psychiatry, 9, 114-29. (UK)
135. WRIGHT, S., GOURNAY, K., GLORNEY, E. et al. (2000). Dual diagnosis in the suburbs: prevalence, need, and in-patient service use. Social Psychiatry and Psychiatric Epidemiology, 35, 297-304. (USA)
136. WU, L.-T., KOUZIS, A.C. & LEAP, P.J. (1999). Influence of comorbid alcohol and psychiatric disorders on utilisation of mental health services in the National Comorbidity Survey. American Journal of Psychiatry, 156, 1230-6. (USA)
137. ZIEDONIS, D.M. & KOSTEN, T.R. (1991). Pharmacotherapy improves treatment outcome in depressed cocaine addicts. Journal of Psychoactive Drugs, 23, 417-25. (USA)
138. ZIMMET, S.V., STROUS, R.D., BURGESS, E.S. et al. (2000). Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of Clinical Psychopharmacology, 20, 94-8. (USA)